Movicolon Naturel (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polymer that is not absorbed from the gut. It creates an osmotic gradient that draws water into the intestinal lumen, while the accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) help maintain normal electrolyte balance. The resulting increase in fluid softens stool and stimulates peristalsis, facilitating bowel movements.

The specific dose of Movicolon Naturel is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. Dosage may differ for constipation relief versus bowel preparation, and the prescriber will provide written instructions on the amount of powder to mix with water and the timing of administration.

Safety in pregnancy and lactation has not been fully established. The product should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their doctor.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with stimulant laxatives, Movicolon Naturel (macrogol 3350‑based) acts osmotically, softening stool without directly stimulating intestinal muscle, which often results in fewer cramping side effects. Unlike saline laxatives, it includes electrolytes to reduce the risk of significant electrolyte shifts. It is generally preferred for chronic constipation and bowel preparation when a gentle, well‑tolerated option is desired.

Movicolon Naturel should be stored at ambient temperature, below 25 °C, in its original packaging. The container must be kept tightly closed to protect the powder from moisture and humidity, which could affect product stability. Keep the product out of direct sunlight and away from sources of heat.

The powder is reconstituted in a measured amount of water as directed by the prescriber, typically 125 mL to 250 mL, and the solution is consumed orally. It may be taken with or without food, but patients should follow the specific timing instructions (e.g., on an empty stomach for bowel preparation). The mixture should be shaken gently to ensure complete dissolution before drinking.

Although uncommon, serious adverse events can include severe electrolyte disturbances such as hypernatremia or hypokalemia, marked dehydration, and allergic reactions presenting as rash, swelling, or difficulty breathing. Patients experiencing intense abdominal pain, persistent diarrhoea, or signs of electrolyte imbalance should seek immediate medical attention. Monitoring is especially important in individuals with renal, cardiac, or hepatic disease.

Movicolon Naturel is contraindicated in patients with known or suspected intestinal obstruction, perforation, or an active flare‑up of inflammatory bowel disease, as well as in those with severe renal impairment where electrolyte handling is compromised. Individuals with hypersensitivity to any of the listed ingredients should avoid the product. Use should be carefully evaluated by a healthcare professional in patients with heart failure or on medications that affect fluid and electrolyte balance.